Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate the safety and effectiveness of Juvederm(R) Ultra XC Injectable Gel for lip augmentation


Clinical Trial Description

All subjects were randomized to either the treatment group, Juvederm(R) Ultra XC Injectable Gel, or to the control group (no treatment). At month 3, subjects in the control group crossed over to the treatment group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01197495
Study type Interventional
Source Allergan
Contact
Status Completed
Phase N/A
Start date August 1, 2010
Completion date June 15, 2015

See also
  Status Clinical Trial Phase
Completed NCT04540913 - RHA® 3 Versus Restylane-L® for Lip Augmentation
Completed NCT03320824 - New Dermal Filler for Lip Augmentation N/A
Completed NCT05730543 - Ethnic Lip Augmentation With Hyaluronic Acid Filler Phase 3
Completed NCT04839692 - Assessment and Augmentation of Lip Appearance in Specific Study Populations Phase 4
Completed NCT03967444 - Study to Evaluate Satisfaction After Treatment With Kysse N/A
Terminated NCT04299295 - To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area. N/A
Completed NCT01629134 - Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips N/A
Terminated NCT04029545 - A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation Phase 3
Active, not recruiting NCT05342753 - Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects N/A
Completed NCT00935272 - Safety/Efficacy Study of Restylane® in Lip Augmentation N/A
Recruiting NCT05314504 - Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China N/A
Completed NCT04029519 - A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation Phase 3
Completed NCT03796728 - A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation Phase 4